You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
暗盤前瞻 | 堃博醫療一手中籤率6.58%,大機構看好,國配貨源集中
uSMART盈立智投 09-23 15:38

uSMART盈立智投9月23日消息,堃博醫療今日公佈中籤結果,並將於16:15-18:30進行暗盤交易。

小結

海倫司首日30%的漲幅也未能提振新股市場,堃博醫療的散戶和機構認購熱情都不高,公開僅11倍,國配4倍,一方面市場對B類新股審美疲勞,在大市疲弱的背景下投資者對未盈利新股更加謹慎,另一方面近100億港元的估值也讓投資者不敢下重手,畢竟公司所處的介入呼吸病學導航市場空間不大。

不過配售結果也顯示出一些積極信息,由於認購冷清,沒有觸發回撥機制,僅5663名散戶中籤,持股佔比僅10%,15%的綠鞋可以承接拋壓。

貨源比較集中,國配前25大承配人幾乎包攬所有股份,最大承配人認購了1200萬股,即2.2億港元,且該投資者不是基石,說明有大機構看好。

配售簡況

1、發售價:18.7港元,爲招股價區間17.2港元—18.7港元的上限

2、上市市值:98.29億港元

3、一手市值:9350港元,每手500股

4、有效申購人數:30993名,甲組30945名,乙組48名

5、實際中籤人數:5663名,中一手的爲4616名

6、中籤概況:一手中籤率6.58%,申購16手穩中1手,甲尾中24手,乙頭中94手,頂頭槌1張

7、公開認購倍數:11.13倍,甲組15.82倍,乙組6.44倍

8、國際發售:認購4.1倍,103名承配人,前25名承配人共獲配98.47%的發行股份

9、回撥情況:公開佔比10%,國配佔比90%

10、基石投資者:10名,共認購42.3%發售股份

11、超額配股權:國際發售已超額分配1340.3萬股股份,佔發售股份的15%

12、穩定價格操作人:高盛,穩價結束日爲2021年10月16日

注:以上佔比均假設超額配股權未獲行使

分配基準

股權集中度

基石投資者

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account